Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 6/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.38 |
| ▸ | TP53 | P04637 | 3/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 8/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10005501 | 0.95 | THRB (0.43) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL10005503 | 0.94 | THRB (0.41) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL13415076 | 0.88 | THRB (0.44) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL23975544 | 0.84 | THRB (0.60) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL16546274 | 0.83 | THRB (0.48) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL24821538 | 0.82 | ALDH1A1 (0.50) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL17770846 | 0.81 | THRB (0.44) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL6251603 | 0.81 | THRB (0.44) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL23741915 | 0.81 | ALDH1A1 (0.53) | THRBTSHRHPGDALDH1A1TP53 | |
| SCHEMBL14368846 | 0.81 | THRB (0.41) | THRBTSHRALDH1A1ACHESMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190023921-A1 | AQUEOUS DISPERSION, METHOD FOR MANUFACTURING THE SAME, AND IMAGE FORMING METHOD | FUJIFILM CORPORATION (JP) | 2019-01-24 | — | — | US | disclosed |
| US-20150059605-A1 | RESIN COMPOSITION FOR LASER ENGRAVING, FLEXOGRAPHIC PRINTING PLATE PRECURSOR FOR LASER ENGRAVING AND PROCESS FOR PRODUCING SAME, AND FLEXOGRAPHIC PRINTING PLATE AND PROCESS FOR MAKING SAME | FUJIFILM CORPORATION (JP) | 2015-03-05 | — | — | US | disclosed |
| US-20120016050-A1 | Monoisocyanate-Acrylate Monomers and Products Ulitilizing the Same | LEON JOSEPH A (US) | 2012-01-19 | — | — | US | disclosed |
| US-20120016050-A1 | Monoisocyanate-Acrylate Monomers and Products Ulitilizing the Same | LEON JOSEPH A (US) | 2012-01-19 | — | — | US | disclosed |
| WO-2010074763-A1 | MONOISOCYANATE-ACRYLATE MONOMERS AND PRODUCTS UTILIZING THE SAME | BOMAR SPECIALTIES COMPANY (US) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016050-A1 | Monoisocyanate-Acrylate Monomers and Products Ulitilizing the Same | DOHH, ESD, DACH1 | THRB 2957/4885TSHR 3171/4885HPGD 1235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.